Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older… EP News Bureau Oct 2, 2020 It was previously approved for the treatment of XLH with radiographic evidence of bone disease in children one year of age and…
US FDA grants approval to Ultragenyx Pharmaceutical for Crysvita EP News Bureau Jun 19, 2020 The drug has been approved to treat patients with tumor-induced osteomalacia (TIO), a rare disease that is characterized by the…
